Spring Bank Pharmaceuticals Inc. | Key People and Executives
Martin J. Driscoll
Chairman, President & Chief Executive Officer
Radhakrishnan P. Iyer
Director & Chief Scientific Officer
Scott Andrew Smith
Independent Director
David A. Arkowitz
Independent Director
Christiana Goh Bardon
Independent Director
Todd C. Brady
Independent Director
Timothy P. Clackson
Independent Director
Kurt M. Eichler
Independent Director
Martin J. Driscoll
Chairman, President & Chief Executive Officer
Donald Mitchell
Vice President-Operations & Corporate Development
Jonathan P. Freve
Chief Financial Officer, Secretary & Treasurer
Nezam Afdhal
Chief Medical Officer
Radhakrishnan P. Iyer
Director & Chief Scientific Officer
Kevin Leach
VP-Nonclinical & Translational Research
Garrett M. Winslow
Vice President-Legal & General Counsel
Scott Andrew Smith
Independent Director
David A. Arkowitz
Independent Director
Christiana Goh Bardon
Independent Director
Todd C. Brady
Independent Director
Timothy P. Clackson
Independent Director
Kurt M. Eichler
Independent Director
| Address |
35 Parkwood Drive
Hopkinton Massachusetts 01748
United States
|
|
Employees
|
- |
| Website |
http://www.springbankpharm.com |
| Updated |
07/08/2019 |
| Spring Bank Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its pipeline include RIG-I & STING Agonists platforms. The company was founded by Douglas J. |
